Dorothy J. Donnelly - Concepedia

Author

Dorothy J. Donnelly

Cancer Research UK Manchester Institute

Also Known As

D. J. DONNELLY, D. J. Donnelly, D.J. Donnelly, Dorothy Donnelly, Dorothy J. Donnelly

Publications

471

Citations

H-Index

Concepts

All Affiliations

Cancer Research UK Manchester Institute Trinity College Dublin Cancer Research UK University of Manchester

About

Dorothy J. Donnelly is an author at Cancer Research UK Manchester Institute specializing in medicine, medicinal chemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	261
2	Natural Sciences	3	3	142
3	Cell Biology	3	3	172
4	Biochemistry	1	1	68
5	Chemical Biology	1	1	68

Dorothy J. Donnelly

Publications

441

Citations

H-Index

Page 1

	Year	Citations
Lomeguatrib, a Potent Inhibitor of <i>O</i>6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors Malcolm Ranson, Mark R. Middleton, John Bridgewater, Clinical Cancer Research	2006	142
O6-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts Mark R. Middleton, Jane Kelly, Nicholas Thatcher, International Journal of Cancer Chemoprevention StrategyTumour GrowthA375m Melanoma XenograftsDermatologyTumor Biology	2000	77
Inactivation of <i>O</i><sup>6</sup>-Alkylguanine-DNA Alkyltransferase. 1. Novel <i>O</i><sup>6</sup>-(Hetarylmethyl)guanines Having Basic Rings in the Side Chain R. Stanley McElhinney, Dorothy J. Donnelly, Joan E. McCormick, Journal of Medicinal Chemistry Bioorganic ChemistryGeneticsMolecular BiologyMolecular GeneticsHeterocycle Chemistry	1998	68
O6-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts Mark R. Middleton, Jane Kelly, Nicholas Thatcher, International Journal of Cancer Tumour GrowthA375m Melanoma XenograftsDermatologyTumor BiologyMedicinal Chemistry	2000	53
Effect of <i>O</i><sup>6</sup>‐(4‐bromothenyl)guanine on different temozolomide schedules in a human melanoma xenograft model Mark R. Middleton, Nicholas Thatcher, T. Brian H. McMurry, International Journal of Cancer Daily TemozolomideOncologyMedicinePhotocarcinogenesisMelanoma	2002	42
QSAR and Chemical Read-Across Analysis of 370 Potential MGMT Inactivators to Identify the Structural Features Influencing Inactivation Potency Guohui Sun, Peiying Bai, Tengjiao Fan, Pharmaceutics	2023	26
Synthesis of Heterocyclic-Substituted Chromones and Related Compounds as Potential Anticancer Agents<sup>1</sup> Dorothy J. Donnelly, Rosalie Geoghegan, Conor O'Brien, Journal of Medicinal Chemistry Altmetric Attention ScoreOrganic ChemistryChemistryHeterocycle ChemistryRelated Compounds	1965	21
Chalcone dihalides—II Dorothy J. Donnelly, J. A. DONNELLY, E.M. Philbin Tetrahedron	1972	12

Page 1